![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, May 22, 2021 10:52:49 PM
Brilacidin starts killing Covid 19 in the serum shortly after infusion. It does not require conversion to an active form like Remdesivir and Pfizers PF 07321332..Brilacidin is the only antiviral being studied which is viruidal. It attaches to the viral coat and destroys the virus shortly after contact.
The Pfizer drug is a prodrug, like Remdesivir, and has to be activated to its effective form.
In addition testing at the RBL demonstrated that Brilacidin prevents viral attachment to the cells.Computer simulations showed it may deactivate the virus's main protease.
Bliacidin has a number of anti-inflammatory properties which may limit the Covid 19 inflammatory cascade which leads to many complications including pulmonary failure.
It broad spectrum antibiotic may reduce the secondary infection rate in hospitalized patients which has been reported as high as 8%
Brilacidin has been successful in all of its previous studies. The Phase 2 study is soon to be fully enrolled.
GLTA,Farrell
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM